ARTHEx Biotech, spin-off of the University of Valencia, obtains €42 M to advance in the treatment of myotonic dystrophy 05/05/23 The company ARTHEx Biotech has just announced the closing of a funding round of 42 million euros to progress with its compound ATX-01, a new drug aimed at the treatment of type 1 myotonic dystrophy...[Read more]
SIMODAR is born, a spin-off of the University of Valencia for the training of machine operators through real-time simulation 28/04/23 A new spin-off of the University of Valencia will implement virtual reality tools for the education and training of machine operators. Learning will be done in a safe environment, using...[Read more]
